Quick Summary:
Experience informed strategy-building and reshape your market trajectory with our comprehensive report on the Global Animal Antibiotics and Antimicrobials Market - projected to achieve exceptional growth and reach a market worth of US$7 Billion by 2030. Situated in a thriving industry, identified at a robust US$4.7 billion in 2022, this report brings you the incisive insights required to effectively navigate this progressive sector. With sector specific analysis such as the promising growth of the Tetracycline segment, you can make decisive and informed investment decisions to maximise your market share.
The rich tapestry of the Animal Antibiotics and Antimicrobials market is distinctly international, with significant opportunities earmarked in both established and developing economies. In the anticipated sizeable expansion in the US market and the forecasted fast growth in China, companies have much to gain from making well-informed market entries and strategic moves. In addition to this, the report features an in-depth competition overview, featuring 36 noteworthy competitors, to help you frame your competitive edge. By purchasing this market research report, you'll gain a veritable roadmap to imminent industry trends, investment pockets, key player activities and more.
Global Animal Antibiotics and Antimicrobials Market to Reach $7 Billion by 2030
The global market for Animal Antibiotics and Antimicrobials estimated at US$4.7 Billion in the year 2022, is projected to reach a revised size of US$7 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2022-2030. Tetracycline, one of the segments analyzed in the report, is projected to record 5.7% CAGR and reach US$3.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Penicillin segment is readjusted to a revised 4.9% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 8.5% CAGR
The Animal Antibiotics and Antimicrobials market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 8.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.Select Competitors (Total 36 Featured) -
- Bayer AG
- Boehringer Ingelheim GmbH
- Ceva Sante Animale
- Dechra Pharmaceuticals PLC
- Eli Lilly and Company
- Merck & Co., Inc.
- Sanofi
- Vetoquinol S.A.
- Virbac
- Zoetis, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Animal Antibiotics and Antimicrobials?
What is the growth rate of the Global Market for Animal Antibiotics and Antimicrobials?
What is the forecasted size of the Global Market for Animal Antibiotics and Antimicrobials?
Who are the key companies in the Global Market for Animal Antibiotics and Antimicrobials?
| Report Attribute | Details |
|---|---|
| No. of Pages | 92 |
| Published | September 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 4.7 Billion |
| Forecasted Market Value ( USD | $ 7 Billion |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Bayer AG
- Boehringer Ingelheim GmbH
- Ceva Sante Animale
- Dechra Pharmaceuticals PLC
- Eli Lilly and Company
- Merck & Co., Inc.
- Sanofi
- Vetoquinol S.A.
- Virbac
- Zoetis, Inc.
